000 03114na a2200289 4500
003 H12O
005 20210625062811.0
008 130622s2011 xxx||||| |||| 00| 0 eng d
040 _cH12O
041 _aeng
100 _aHoenicka, Janet
_91868
_ePsiquiatría
100 _aMartínez Gras, María Isabel
_91870
_ePsiquiatría
100 _9653
_aPalomo Álvarez, Tomás
_d(1989-2010)
_ePsiquiatría
100 _aRodríguez Jiménez, Roberto
_91873
_ePsiquiatría
100 _aRubio Valladolid, Gabriel
_9726
_ePsiquiatría
245 0 3 _aThe anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia
_h[artículo]
260 _bSchizophrenia Research,
_c2011
300 _a128(1-3):15-22.
500 _aFormato Vancouver: Martínez Gras I, Pérez Nievas BG, García Bueno B, Madrigal JL, Andrés Esteban E, Rodríguez Jiménez R, et al. The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia. Schizophr Res. 2011;128(1-3):15-22.
501 _aPMID: 21334179
504 _aContiene 64 referencias
520 _aA number of findings suggest that inflammation plays a role in the pathophysiology of schizophrenia. Taking into account a physiological balance between pro- and anti-inflammatory mediators, we measured the plasma levels of cyclooxygenase-derived mediators and other key pro- and anti-inflammatory transcription factors in peripheral blood mononuclear cells (PBMC). Forty healthy subjects and 46 treated chronic schizophrenic patients with an acutely exacerbated condition who met DSM-IV criteria were included. COX by-products prostaglandin E2 (PGE2) and 15d-prostaglandin J2 (15d-PGJ2) plasma levels were measured by EIA. Peroxisome proliferator-activated receptor gamma (PPARγ) as well as nuclear factor kappaB (NFκB) activity in nuclear extracts from PBMC and expression of its inhibitory subunit IκBα in cytosolic extracts were determined using ELISA-based kits. Schizophrenic patients showed higher plasma levels of pro-inflammatory PGE2 than age-matched controls (p=0.043). On the contrary, levels of anti-inflammatory 15-d-PGJ2 were lower (p=0.004), correlating with a lower expression of its nuclear target, PPARγ in nuclear extracts from PBMC (p=0.001). Although no changes in NFκB activity were observed between patients and healthy controls, the expression of its inhibitory protein IκBα was lower in the patients compared to the controls (p=0.027). These findings suggest that schizophrenia is associated with a systemic imbalance in the plasma levels of pro-inflammatory/anti-inflammatory prostaglandins in favor of the former. Furthermore, the expression and activity of anti-inflammatory PPARγ are diminished in PBMC, which indicates a state of inflammation and blunted anti-inflammatory counterbalancing mechanisms at systemic level in these patients.
710 _9150
_aServicio de Psiquiatría
710 _9625
_aInstituto de Investigación imas12
856 _uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc12461.pdf
_ySolicitar documento
942 _n0
_2ddc
_cART
999 _c12461
_d12461